Viking Therapeutics, Inc. (VKTX) Social Stream



Viking Therapeutics, Inc. (VKTX): $64.23

3.29 (-4.87%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

VIKING THERAPEUTICS INC (VKTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VKTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 9 $28 $12 $18.666 $21.03 -11.24%
2022-01-27 9 $28 $12 $18.25 $21.03 -13.22%
2022-02-10 9 $28 $10 $17.875 $21.03 -15%
2022-04-08 9 $28 $10 $17.375 $21.03 -17.38%
2022-04-28 9 $28 $10 $16 $21.03 -23.92%
2022-07-28 9 $28 $10 $15.428 $21.03 -26.64%
2022-10-10 8 $28 $10 $15.428 $21.03 -26.64%
2022-10-27 8 $28 $10 $15.285 $21.03 -27.32%
2022-12-20 8 $28 $10 $15.714 $21.03 -25.28%
2023-01-06 8 $28 $11 $16.428 $21.03 -21.88%
2023-02-08 8 $28 $11 $16.714 $21.03 -20.52%
2023-02-13 8 $28 $12 $17.142 $21.03 -18.49%
2023-02-23 8 $28 $12 $17.571 $21.03 -16.45%
2023-03-16 10 $28 $12 $18.125 $21.03 -13.81%
2023-03-29 9 $35 $19 $26.777 $21.03 27.33%
2023-04-06 10 $35 $19 $26.777 $21.03 27.33%
2023-04-25 10 $35 $19 $27.333 $21.03 29.97%
2023-04-27 10 $35 $19 $28.666 $21.03 36.31%
2023-05-08 10 $35 $23 $29.222 $21.03 38.95%
2023-05-16 10 $40 $25 $32.625 $21.03 55.14%
2023-05-31 10 $40 $25 $32.555 $21.03 54.8%
2023-11-09 10 $40 $28 $33.666 $21.03 60.09%

The Trend in the Analyst Price Target


VKTX's average price target has moved up $13.77 over the prior 26 months.

VKTX reports an average of 104.92% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-06 10 35 19 26.777 16.68 60.53%
2023-04-27 10 35 19 28.666 19.61 46.18%
2023-05-08 10 35 23 29.222 22.86 27.83%
2023-08-08 10 40 28 33.666 14.22 136.75%
2023-08-10 10 40 28 33.666 14.88 126.25%

VKTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.1 9 1 0 0 0 10

The Trend in the Broker Recommendations


VKTX's average broker recommendation rating worsened by 0.11 over the prior 44 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • VIKING THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 807.92% of all US stocks.
  • In terms of how VIKING THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 2624.14% of that group.
  • In the context of stocks in the small market cap category, VIKING THERAPEUTICS INC's variance in analysts' estimates is lower than -1983.58% of them.
  • VKTX has a higher average analyst price target than 1012.08% of Healthcare stocks.

Stocks similar to VIKING THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are COLL, RDHL, and KMDA.

What is the outlook for VKTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!